Medicare Enrolled
Dr. Tim Sidor, MD
Urology Physician · Parma, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sidor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sidor?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sidor
Dr. Tim Sidor is an urology physician in Parma, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sidor performed 5,465 Medicare services across 3,012 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sidor received a total of $30,464 from 47 pharmaceutical and/or device companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sidor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in OH
$30,464 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,465
Medicare services
Top 6% in OH for urology physician
3,012
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~273 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,160 | $2 | $6 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,066 | $3 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
529 | $80 | $186 |
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
336 | $34 | $94 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
317 | $8 | $16 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
313 | $47 | $202 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
307 | $60 | $122 |
| PSA test (prostate cancer screening) | 300 | $18 | $108 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
208 | $7 | $60 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
207 | $39 | $90 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 117 | $133 | $681 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
60 | $15 | $83 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
58 | $35 | $151 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
53 | $133 | $541 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
49 | $23 | $123 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
46 | $2 | $24 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $103 | $261 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
39 | $74 | $165 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
38 | $24 | $485 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
37 | $171 | $740 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
36 | $62 | $314 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
28 | $34 | $94 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $82 | $563 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
24 | $75 | $1,170 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
22 | $19 | $70 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
17 | $23 | $141 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
14 | $21 | $142 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
13 | $188 | $1,839 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$30,464
Total received (2018-2024)
Avg $4,352/year across 7 years
Top 8% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
322
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26,672 (87.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,792 (12.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$108
2023
$481
2022
$352
2021
$462
2020
$736
2019
$3,627
2018
$24,698
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Blue Earth Diagnostics Limited
$37
Novartis Pharmaceuticals Corporation
$26
Verity Pharmaceuticals Inc.
$16
ABBVIE INC.
$14
Bayer Healthcare Pharmaceuticals Inc.
$14
Top 3 companies account for 73.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$27,013
Amgen Inc.
$364
Bayer HealthCare Pharmaceuticals Inc.
$270
Janssen Biotech, Inc.
$267
Dendreon Pharmaceuticals LLC
$240
Endo Pharmaceuticals Inc.
$212
Blue Earth Diagnostics Limited
$167
Ferring Pharmaceuticals Inc.
$139
C. R. Bard, Inc. & Subsidiaries
$136
Allergan, Inc.
$133
Antares Pharma, Inc.
$109
TOLMAR Pharmaceuticals, Inc.
$106
Verity Pharmaceuticals Inc.
$88
AbbVie, Inc.
$81
Medtronic USA, Inc.
$73
Bard Access Systems, Inc.
$69
Bayer Healthcare Pharmaceuticals Inc.
$64
PFIZER INC.
$63
Allergan Inc.
$59
DENTSPLY IH Inc.
$59
MEDIVATION FIELD SOLUTIONS LLC
$57
Acerus Pharmaceuticals Corporation
$57
ABBVIE INC.
$56
Myovant Sciences Inc.
$54
Rochester Medical Corporation
$46
AbbVie Inc.
$42
Mission Pharmacal Company
$38
Coloplast Corp
$35
Axonics Modulation Technologies, Inc.
$33
Progenics Pharmaceuticals, Inc.
$29
Telix Pharmaceuticals
$27
COLOPLAST CORP
$27
GENZYME CORPORATION
$26
Novartis Pharmaceuticals Corporation
$26
UROGEN PHARMA, INC.
$24
Avadel Specialty Pharmaceuticals, LLC
$23
Sumitomo Pharma America, Inc.
$20
Merck Sharp & Dohme LLC
$19
Accord Healthcare, Inc.
$16
Boston Scientific Corporation
$14
Foundation Medicine, Inc.
$14
Photocure Inc
$13
AstraZeneca Pharmaceuticals LP
$13
Metuchen Pharmaceuticals
$13
Zyla Life Sciences, Inc.
$11
Sun Pharmaceutical Industries Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 90.8% of all-time payments
Associated products mentioned in payments ›
AVEED · Androgel · Aquoral · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · CYSVIEW · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEXIVA · GEMTESA · Genesis · ILLUCCIX · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MIRABEGRON · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Prolia · SPEEDICATH · SPRIX · SpeediCath · Stendra · Synthroid · TESTOPEL · Trelstar · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for urology physician in OH.
Geographic Context
Urology physicians within 10 mi
79
Per 100K population
6.3
County median income
$62,823
Nearest hospital
PARMA COMMUNITY GENERAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sidor is a clinical cardiology specialist, with above-average Medicare volume (top 6% in OH), with speaking/promotional industry engagement in the top 8% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sidor experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Sidor performed 1,160 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sidor receive payments from pharmaceutical companies?
Yes. Dr. Sidor received a total of $30,464 from 47 companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sidor's costs compare to other urology physicians in Parma?
Dr. Sidor's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sidor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Parma
Browse urology physicians in Parma ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology